SERA
SERA PROGNOSTICS, INC.Company Information
- Company Name
- SERA PROGNOSTICS, INC.
- CIK
- CIK0001534969
- Category
- <br>Emerging growth company
- Ticker: Exchange
- SERA: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8071
- SIC Description
- Services-Medical Laboratories
- Ticker
- SERA
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-09-10
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 243,919
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 17,056,600
- Shares outstanding
- 50,476,874
- Ownership
- 33.79%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- 0.00%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 4 | 4 | 4 | 4 | 5 | 5 | 4 | 3 | 5 | 4 | 4 | 10 | ||||||
| Marketable Securities Current | 42 | 43 | 35 | 39 | 35 | 41 | 42 | 47 | 46 | 49 | 45 | 36 | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Receivables Net Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 11 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets Current | 48 | 50 | 41 | 44 | 41 | 47 | 48 | 51 | 52 | 54 | 61 | 48 | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | ||||||
| Marketable Securities Noncurrent | 34 | 39 | 57 | 59 | 68 | 68 | 22 | 25 | 30 | 32 | 31 | 39 | ||||||
| Intangible Assets Net Excluding Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | - | 0 | - | ||||||
| Other Assets Noncurrent | 2 | 2 | 3 | 3 | 0 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | ||||||
| Assets | 87 | 94 | 102 | 108 | 112 | 118 | 73 | 79 | 85 | 90 | 95 | 90 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accrued Liabilities And Other Liabilities | 3 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | ||||||
| Finance Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Contract With Customer Liability Current | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 9 | ||||||
| Liabilities Current | 24 | 23 | 24 | 24 | 24 | 23 | 25 | 24 | 25 | 25 | 24 | 14 | ||||||
| Finance Lease Liability Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 3 | 3 | 2 | 2 | - | - | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
| Liabilities | 27 | 26 | 27 | 26 | 24 | 23 | 25 | 24 | 25 | 25 | 25 | 15 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 389 | 388 | 387 | 386 | 384 | 383 | 328 | 326 | 323 | 320 | 317 | 315 | ||||||
| Additional Paid In Capital Common Stock | - | - | - | - | - | - | 328 | - | - | - | 317 | - | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | -1 | ||||||
| Retained Earnings Accumulated Deficit | -329 | -320 | -312 | -304 | -296 | -288 | -280 | -271 | -263 | -255 | -247 | -239 | ||||||
| Stockholders Equity | 59 | 68 | 75 | 82 | 88 | 95 | 48 | 55 | 60 | 65 | 70 | 75 | ||||||
| Liabilities And Stockholders Equity | 87 | 94 | 102 | 108 | 112 | 118 | 73 | 79 | 85 | 90 | 95 | 90 | ||||||
| Common Class A | -1 | 2 | 1 | -2 | -0 | 2 | 2 | 1 | 0 | 0 | 3 | 0 | ||||||
| Common Class B | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialSERA PROGNOSTICS, INC. (SERA) — SEC Financial Statements & Analysis
SERA PROGNOSTICS, INC. (SERA) is a services-medical laboratories company, incorporated in DE. SERA PROGNOSTICS, INC. trades on Nasdaq as: SERA. SERA PROGNOSTICS, INC. (SERA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, SERA PROGNOSTICS, INC. carries a market cap of $91.87M, a P/E ratio of -2.76x, a P/B ratio of 1.55x, a P/S ratio of 1312.40x, an enterprise value of $87.47M, and an EV/EBITDA multiple of -2.40x. On profitability, it posts a gross margin of 110.00%, an operating margin of -53282.86%, a net margin of -47475.71%, a Return on Equity (ROE) of -45.03%, a Return on Assets (ROA) of -33.47%, and a Return on Invested Capital (ROIC) of -53.97%. Per share, it reports EPS of $-0.66, diluted EPS of $-0.66, free cash flow per share of $-0.56, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -35.19% year-over-year, net income growth of 1.53% year-over-year, and EPS growth of -1.30% year-over-year. On the balance sheet, it maintains a current ratio of 1.98x, a quick ratio of 1.91x, working capital of $23.78M, a debt-to-equity ratio of 0.46x, a debt ratio of 0.32, an interest coverage ratio of -5328.29x, free cash flow of $-28.15M (TTM), and net debt of $-4.40M. Figures sourced from SEC EDGAR.
- Market Cap
- $91.87M
- P/E TTM
- -2.76x
- EPS TTM
- $-0.66
- P/B TTM
- 1.55x
- ROE TTM
- -45.03%
- ROA TTM
- -33.47%
- Debt To Equity
- 0.46x
- Free Cash Flow TTM
- $-28.15M
- Net Revenue TTM Growth 1Y
- -35.19%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is SERA PROGNOSTICS, INC. in?
SERA PROGNOSTICS, INC. (SERA) operates in the Services-Medical Laboratories industry.
What exchange does SERA trade on?
SERA PROGNOSTICS, INC. (SERA) trades on the Nasdaq.
Where is SERA PROGNOSTICS, INC. incorporated?
SERA PROGNOSTICS, INC. is incorporated in DE.
When was SERA PROGNOSTICS, INC. (SERA)'s most recent SEC filing?
SERA PROGNOSTICS, INC. (SERA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is SERA's market cap?
SERA PROGNOSTICS, INC. (SERA) has a market capitalization of $91.87M as of 2026-06-30.
What is SERA's EPS (earnings per share)?
SERA PROGNOSTICS, INC. (SERA)'s trailing twelve month EPS is $-0.66 as of 2026-06-30.
What is SERA's ROE (return on equity)?
SERA PROGNOSTICS, INC. (SERA)'s trailing twelve month Return on Equity (ROE) is -45.03% as of 2026-06-30.
What is SERA's ROA (return on assets)?
SERA PROGNOSTICS, INC. (SERA)'s trailing twelve month Return on Assets (ROA) is -33.47% as of 2026-06-30.
What is SERA's ROIC (return on invested capital)?
SERA PROGNOSTICS, INC. (SERA)'s trailing twelve month Return on Invested Capital (ROIC) is -53.97% as of 2026-06-30.
What is SERA's EV/EBITDA?
SERA PROGNOSTICS, INC. (SERA)'s trailing twelve month EV/EBITDA is -2.40x as of 2026-06-30.